Back to search

United Kingdom· GB-APID-38936311000001106

Levomepromazine 100mg tablets

A levomepromazine product containing levomepromazine, registered in United Kingdom by Morningside Healthcare Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC N05AA02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLevomepromazine 100mg tabletsATCN05AA02REGISTER NO.GB-APID-3893631100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Levomepromazine is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AA02 (levomepromazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Levomepromazine · ATC N05AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levomepromazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.30 in Italy to $6.20 in Switzerland — a ×4.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levomepromazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.20
  • IT Italy$1.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Levomepromazine
Manufacturer
Morningside Healthcare Ltd
Country
United Kingdom (GB)
ATC code
N05AA02
ATC class
Levomepromazine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5055132717406
  • gtin
    5055132717444

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for levomepromazine.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levomepromazine · interactions on record

349 records

  • 44 severe
  • 263 moderate
  • 8 minor

Most severe, free to view

  • MetoclopramideA03FA01severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levomepromazine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levomepromazine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Nozinan
  • Belgium · Nozinan
  • Czechia · Tisercin
  • Germany · Levomepromazin Aspire, Levomepromazin Neuraxpharm
  • Denmark · Levomepromazine Aspire
  • Estonia · Levomepromazine Orion
  • Spain · Sinogan
  • Finland · Levomepromazine Aspire, Levomepromazine Orion
  • France · Nozinan
  • Greece · Nozinan
  • Croatia · Nozinan
  • Hungary · Tisercin
  • Ireland · Nozinan
  • Italy · Nozinan
  • Lithuania · Tisercin
  • Luxembourg · Nozinan
  • Latvia · Tisercin
  • Netherlands · Nozinan
  • Norway · Levomepromazine Aspire, Levomepromazine Orion
  • Poland · Levomentis, Tisercin
  • Portugal · Nozinan
  • Romania · Levomepromazin Aspire, Levomepromazin Terapia
  • Sweden · Levomepromazine Aspire, Levomepromazine Orion
  • Slovakia · Tisercin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/784d4886-fe84-445e-98a7-404aedb8117e
GET /v1/drugs/784d4886-fe84-445e-98a7-404aedb8117e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "38936311000001106",
  "desc": "Levomepromazine 100mg tablets (Morningside Healthcare Ltd)",
  "form": "Oral tablet",
  "vpid": "27946311000001103",
  "source": "dmd",
  "vtm_id": "776520002",
  "strength": "100 mg",
  "substance": "Levomepromazine",
  "ingredient": "Levomepromazine maleate",
  "supplier_code": "10246711000001109"
}

See everything about levomepromazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.